Microbot Medical Inc. financial data

Symbol
MBOT on Nasdaq
Location
Hingham, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.5K % +326%
Debt-to-equity 7.62 % -79.9%
Return On Equity -37.1 % +83%
Return On Assets -34.4 % +78.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.2M shares +297%
Common Stock, Shares, Outstanding 65.8M shares +295%
Entity Public Float 15.9M USD -58.3%
Common Stock, Value, Issued 659K USD +292%
Weighted Average Number of Shares Outstanding, Basic 48.1M shares +192%
Weighted Average Number of Shares Outstanding, Diluted 48.1M shares +192%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.73M USD +16.4%
General and Administrative Expense 7.31M USD +62.9%
Operating Income (Loss) -14M USD -36.8%
Net Income (Loss) Attributable to Parent -13.1M USD -16.6%
Earnings Per Share, Basic 0 USD/shares +42.9%
Earnings Per Share, Diluted 0 USD/shares +42.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.7M USD +1300%
Marketable Securities, Current 73.5M USD +1803%
Cash, Cash Equivalents, and Short-term Investments 80.2M USD +1748%
Other Assets, Current 1.34M USD
Assets, Current 80.8M USD +1517%
Property, Plant and Equipment, Net 78K USD -21.2%
Operating Lease, Right-of-Use Asset 897K USD +687%
Assets 81.8M USD +1470%
Accounts Payable, Current 509K USD +107%
Employee-related Liabilities, Current 1.41M USD +94.3%
Accrued Liabilities, Current 2.13M USD +101%
Liabilities, Current 2.93M USD +114%
Operating Lease, Liability, Noncurrent 602K USD +1976%
Liabilities 3.54M USD +153%
Retained Earnings (Accumulated Deficit) -101M USD -14.9%
Stockholders' Equity Attributable to Parent 78.2M USD +1954%
Liabilities and Equity 81.8M USD +1470%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.87M USD -18.8%
Net Cash Provided by (Used in) Financing Activities 27.8M USD +1060%
Net Cash Provided by (Used in) Investing Activities -24.8M USD -1834%
Common Stock, Shares Authorized 120M shares +100%
Common Stock, Shares, Issued 65.8M shares +295%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 102K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.76M USD +1182%
Interest Paid, Excluding Capitalized Interest, Operating Activities 40K USD +14.3%
Deferred Tax Assets, Valuation Allowance 118M USD +2.03%
Deferred Tax Assets, Gross 118M USD +1.75%
Operating Lease, Liability 899K USD
Payments to Acquire Property, Plant, and Equipment 13K USD -7.14%
Lessee, Operating Lease, Liability, to be Paid 1.04M USD
Property, Plant and Equipment, Gross 664K USD +3.91%
Operating Lease, Liability, Current 297K USD +357%
Lessee, Operating Lease, Liability, to be Paid, Year Two 247K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 298K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 145K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 229K USD
Deferred Tax Assets, Operating Loss Carryforwards 118M USD +2.19%
Preferred Stock, Shares Authorized 1M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 189K USD
Operating Lease, Payments 75K USD -19.4%
Depreciation, Depletion and Amortization 15K USD -46.4%
Deferred Tax Assets, Net of Valuation Allowance 30K USD -91.6%